Señales en vivo de 063160.KS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 abr 2024 @ 21:51):

Stats
Volumen de hoy	9 073.00
Volumen promedio	19 187.00
Capitalización de mercado	134.68B
EPS	KRW0 ( 2024-04-25 )
Próxima fecha de ganancias	( KRW0 ) 2024-07-26
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	-5.82
ATR14	KRW27.01 (0.11%)

Volumen Correlación

Largo: 0.10 (neutral)

Corto: 0.24 (neutral)

Signal:(38.902) Neutral

CKD Bio Corp. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CKD Bio Corp. Correlación - Moneda/Commodity

0.70
( moderate )

0.23
( neutral )

-0.33
( neutral )

0.53
( weak )

-0.05
( neutral )

0.28
( neutral )

CKD Bio Corp. Finanzas

Annual	2023
Ingresos:	KRW160.35B
Beneficio Bruto:	KRW5.01B (3.12 %)
EPS:	KRW-4 409.90

FY	2023
Ingresos:	KRW160.35B
Beneficio Bruto:	KRW5.01B (3.12 %)
EPS:	KRW-4 409.90

FY	2022
Ingresos:	KRW156.04B
Beneficio Bruto:	KRW16.79B (10.76 %)
EPS:	KRW-3 044.61

FY	2021
Ingresos:	KRW142.24B
Beneficio Bruto:	KRW13.31B (9.35 %)
EPS:	KRW-1 215.54

Financial Reports:

No articles found.

CKD Bio Corp.

CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, ß-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The company also provides contract research and development, and manufacturing services for active pharmaceutical ingredients and intermediates, and probiotics. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.